Scaffolds for retinal pigment epithelial cell transplantation in age-related macular degeneration

Corina E. White, Ronke M. Olabisi

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


In several retinal degenerative diseases, including age-related macular degeneration, the retinal pigment epithelium, a highly functionalized cell monolayer, becomes dysfunctional. These retinal diseases are marked by early retinal pigment epithelium dysfunction reducing its ability to maintain a healthy retina, hence making the retinal pigment epithelium an attractive target for treatment. Cell therapies, including bolus cell injections, have been investigated with mixed results. Since bolus cell injection does not promote the proper monolayer architecture, scaffolds seeded with retinal pigment epithelium cells and then implanted have been increasingly investigated. Such cell-seeded scaffolds address both the dysfunction of the retinal pigment epithelium cells and age-related retinal changes that inhibit the efficacy of cell-only therapies. Currently, several groups are investigating retinal therapies using seeded cells from a number of cell sources on a variety of scaffolds, such as degradable, non-degradable, natural, and artificial substrates. This review describes the variety of scaffolds that have been developed for the implantation of retinal pigment epithelium cells.

Original languageEnglish (US)
JournalJournal of Tissue Engineering
StatePublished - Jan 1 2017

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering


  • Scaffolds
  • age-related macular degeneration
  • retina
  • retinal pigment epithelium


Dive into the research topics of 'Scaffolds for retinal pigment epithelial cell transplantation in age-related macular degeneration'. Together they form a unique fingerprint.

Cite this